RecruitingPhase 4NCT06526117

Stroke Prevention in Nigeria 2 Trial

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vanderbilt University Medical Center
Principal Investigator
Michael R DeBaun, MD, MPH, MD
Vanderbilt University Medical Center
Intervention
Hydroxyurea(drug)
Enrollment
220 enrolled
Eligibility
5-12 years · All sexes
Timeline
2024 – 2030

Study locations (2)

Collaborators

Aminu Kano Teaching Hospital · Murtala Muhammed Specialist Hospital · National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06526117 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials